Regular Article
Metabolic Activation of the Potent Carcinogen Dibenzo[a,h]anthracene by cDNA-Expressed Human Cytochromes P450

https://doi.org/10.1006/abbi.1996.0161Get rights and content

Abstract

The metabolic activation of the potent carcinogen dibenzo[a,h]anthracene (DB[a,h]A) was investigated with recombinant human cytochrome P450 enzymes 1A2, 2B6, 2C8, 2C9, 2E1, 3A3, 3A4, and 3A5 expressed in hepatoma G2 cells and with 14 different human liver microsomes. Three dihydrodiols, three phenols, and one diphenol were formed and separated by high-performance liquid chromatography and identified by UV absorption and mass spectra. Of all P450s tested, 1A2 and 2C9 were the most active and 2B6 was moderately active in the rate of total DB[a,h]A metabolism (2.5- to 12-fold greater activity than that for other P450s). Thetrans-3,4-dihydrodiol, generally recognized as a precursor of the ultimate carcinogenic 3,4-diol-1,2-epoxides, was produced most actively by 2C9, then 1A2 and 2B6. The values of enzymatic kinetics (KmandVmax) indicated that 2C9 had the highest catalytic efficiency (Vmax/Km= 9.7) in the formation of 3,4-dihydrodiol, in contrast to 1A2 (5.9) and 2B6 (4.4). 1A2 had the highest activity toward production of the 1,2-dihydrodiol, which is considered to be a weakly carcinogenic metabolite. Although specific activities of human liver microsomes in overall metabolism of DB[a,h]A markedly differed between individuals, metabolic patterns were observed similar to that generated from 1A2. Since human 1A1, a predominant enzyme for metabolism of polycyclic aromatic hydrocarbons, is not significantly expressed in the liver, hepatic microsomal 2C9, 1A2, and 2B6 all probably contribute to the metabolic activation of DB[a,h]A.

References (0)

Cited by (50)

  • Refined CYP2E1<sup>∗</sup> Template<sup>∗∗</sup> system to decipher the ligand-interactions

    2021, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    The differences in stability of bi-molecule sittings among chrysene derivatives might yield the dissimilar outcome. CYP2E1 mediates mainly the 5,6-oxidation of dibenzo[a,h]anthracene (DBahA) [42]. A placement of DBahA for the 5,6-oxidation was available at Rings E-D-B-eAB-eA as an angled-placement (Fig. 6L).

  • Prediction of regioselectivity and preferred order of metabolisms on CYP1A2-mediated reactions part 3: Difference in substrate specificity of human and rodent CYP1A2 and the refinement of predicting system

    2019, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    Similar inconsistencies from the order of placements were apparent for the 10,11-oxidations of 7-methylbenz[c]acridine (7-MBcAC) and 7,12-dimethylbenzo[a]anthracene (DMBA). Both the 10,11-oxidations were not significantly detected in hCYP1A2 systems [50,51]. In addition, the abundance of the 10,11-oxidation of benzo[a]anthracene was less than those of the 8,9-oxidation (Data not shown, Rings E-eC1-eC4-eC6) and the 5,6-oxidation (Data not shown, Rings D-E-eC1-eC4).

  • Reconstitution of CYP3A4 active site through assembly of ligand interactions as a grid-template: Solving the modes of the metabolism and inhibition

    2019, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    Dibenzo[a,h]anthracene is metabolized to primarily the 5,6-dihydrodiol, and to the 3,4- and 1,2-dihydrodiols in the decreasing order. Three regio-isomeric phenols and one di-phenol are also detected in recombinant CYP3A4 system [18]. Couple placements of dibenzo[a,h]anthracene were constructed on Core Template of CYP3A4 (Fig. 4).

  • Prediction of regioselectivity and preferred order of metabolisms on CYP1A2-mediated reactions. Part 1. Focusing on polycyclic arenes and the related chemicals

    2016, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    Setting of Gatekeeper at Fjord was further verified with other substrates. CYP1A2 mediates the 3,4-oxidation of DBahA [16]. The placement for the 3,4-oxidation is available at Rings eEa-E-eC1-eC4-eC6 (Fig. 7G).

View all citing articles on Scopus
View full text